FIELD: medicine; pharmacology.
SUBSTANCE: pharmaceutical composition is used for treatment of by-effects and idiphatic syndromes caused by opioids, contains a matrix and a pharmaceutically active substance, and the matrix is executed from ethyl cellulose or polymer on a basis of ethyl cellulose and at least one acyclic spirit; thereat the matrix is diffused and practically not bulking up, and contains naloxone as a pharmaceutically active substance, released from the matrix invariant and prolonged, in amount of 1-50 mg, 5-30 mg preferably, and the most preferably in amount of 5-20 mg.
EFFECT: composition is tolerant at storage.
19 dwg, 16 ex, 2 cl
